Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon ...
The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the ...
Upper Limb Dysfunction Linked to Poor Quality of Life in SLE In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to ...
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug therapy, nipocalimab, met its primary endpoint and multiple key secondary ...
AstraZeneca reported positive results from a Phase III TULIP-SC clinical trial, showing a statistically significant and clinically meaningful reduction in disease activity with the subcutaneous (SC), ...
We are on the cusp of spring, so fundraising walks are blooming, offering the perfect opportunity to support a healthcare cause of your choice. Back in person for the third consecutive year is Walk’n ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results